カテゴリ： 世界, 医療/バイオ, QYResearch

ウイルス様粒子の世界市場2023年：大腸菌、酵母、昆虫細胞、その他

■ 英語タイトル：Global Virus-like Particle Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8505）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8505
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：89
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[ウイルス様粒子の世界市場2023年：大腸菌、酵母、昆虫細胞、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料はウイルス様粒子のグローバル市場について調査・分析し、世界のウイルス様粒子市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（大腸菌、酵母、昆虫細胞、その他）、用途別セグメント分析（ワクチン、治療、バイオイメージング、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、The Native Antigen Company、Creative BioStructure、Creative Biolabs、Leadgene Biomedical、Abcam、ACROBiosystems、Gentarget、VectorBuilderなどが含まれています。ウイルス様粒子のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、ウイルス様粒子市場規模を算出する際に考慮しました。

・ウイルス様粒子市場の概要
- 製品の定義
- ウイルス様粒子の種類別セグメント
- 世界のウイルス様粒子市場規模：タイプ別分析（大腸菌、酵母、昆虫細胞、その他）
- ウイルス様粒子の用途別セグメント
- 世界のウイルス様粒子市場規模：用途別分析（ワクチン、治療、バイオイメージング、その他）
- 世界のウイルス様粒子市場規模予測（2018年-2029年）
- ウイルス様粒子の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- ウイルス様粒子市場の競争状況およびトレンド

・ウイルス様粒子の地域別市場規模
- 北米のウイルス様粒子市場規模（2018年-2029年）
- 米国のウイルス様粒子市場規模（2018年-2029年）
- ヨーロッパのウイルス様粒子市場規模（2018年-2029年）
- アジア太平洋のウイルス様粒子市場規模（2018年-2029年）
- 中国のウイルス様粒子市場規模（2018年-2029年）
- 日本のウイルス様粒子市場規模（2018年-2029年）
- 韓国のウイルス様粒子市場規模（2018年-2029年）
- インドのウイルス様粒子市場規模（2018年-2029年）
- オーストラリアのウイルス様粒子市場規模（2018年-2029年）
- 中南米のウイルス様粒子市場規模（2018年-2029年）
- 中東・アフリカのウイルス様粒子市場規模（2018年-2029年）

・種類別セグメント：大腸菌、酵母、昆虫細胞、その他
- 世界のウイルス様粒子のタイプ別販売量（2018年-2023年）
- 世界のウイルス様粒子のタイプ別売上（2018年-2023年）
- 世界のウイルス様粒子のタイプ別価格

・用途別セグメント：ワクチン、治療、バイオイメージング、その他
- 世界のウイルス様粒子の用途別販売量（2018年-2023年）
- 世界のウイルス様粒子の用途別売上（2018年-2023年）
- 世界のウイルス様粒子の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
The Native Antigen Company、Creative BioStructure、Creative Biolabs、Leadgene Biomedical、Abcam、ACROBiosystems、Gentarget、VectorBuilder

・産業チェーンと販売チャネルの分析
- ウイルス様粒子産業チェーン分析
- ウイルス様粒子の主要原材料
- ウイルス様粒子の販売チャネル
- ウイルス様粒子のディストリビューター
- ウイルス様粒子の主要顧客

・ウイルス様粒子市場ダイナミクス
- ウイルス様粒子の業界動向
- ウイルス様粒子市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Virus-like particles (VLPs) are artificial protein structures with a similar overall structure to their corresponding native viruses. They resemble viruses with self-assembly properties but lose original infectious ability due to genome modifications. VLPs are symmetrically built from hundreds of coat proteins, which can be genetically engineered to present a regular arrangement of epitope chains on the desired positions of the outer surface. Compared with monomeric or oligomeric protein carriers, VLPs are able to provide not only a higher density of foreign proteins per particle but also support a distinctive three-dimensional conformation, which is especially important for the presentation of conformational epitopes. Currently, VLPs have been recognized as one of the most promising and extensively studied molecular carriers or nanoparticles, for a variety of applications.
Highlights
The global Virus-like Particle market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Virus-like Particle is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Virus-like Particle is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Virus-like Particle include The Native Antigen Company, Creative BioStructure, Creative Biolabs, Leadgene Biomedical, Abcam, ACROBiosystems, Gentarget and VectorBuilder, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Virus-like Particle, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Virus-like Particle.
The Virus-like Particle market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Virus-like Particle market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Virus-like Particle manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
The Native Antigen Company
Creative BioStructure
Creative Biolabs
Leadgene Biomedical
Abcam
ACROBiosystems
Gentarget
VectorBuilder
Segment by Type
E. coli
Yeast
Insect Cells
Others
Segment by Application
Vaccine
Therapeutics
Bioimaging
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Virus-like Particle manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Virus-like Particle in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Virus-like Particle Market Overview
1.1 Product Overview and Scope of Virus-like Particle
1.2 Virus-like Particle Segment by Type
1.2.1 Global Virus-like Particle Market Value Comparison by Type (2023-2029)
1.2.2 E. coli
1.2.3 Yeast
1.2.4 Insect Cells
1.2.5 Others
1.3 Virus-like Particle Segment by Application
1.3.1 Global Virus-like Particle Market Value by Application: (2023-2029)
1.3.2 Vaccine
1.3.3 Therapeutics
1.3.4 Bioimaging
1.3.5 Others
1.4 Global Virus-like Particle Market Size Estimates and Forecasts
1.4.1 Global Virus-like Particle Revenue 2018-2029
1.4.2 Global Virus-like Particle Sales 2018-2029
1.4.3 Global Virus-like Particle Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Virus-like Particle Market Competition by Manufacturers
2.1 Global Virus-like Particle Sales Market Share by Manufacturers (2018-2023)
2.2 Global Virus-like Particle Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Virus-like Particle Average Price by Manufacturers (2018-2023)
2.4 Global Virus-like Particle Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Virus-like Particle, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Virus-like Particle, Product Type & Application
2.7 Virus-like Particle Market Competitive Situation and Trends
2.7.1 Virus-like Particle Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Virus-like Particle Players Market Share by Revenue
2.7.3 Global Virus-like Particle Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Virus-like Particle Retrospective Market Scenario by Region
3.1 Global Virus-like Particle Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Virus-like Particle Global Virus-like Particle Sales by Region: 2018-2029
3.2.1 Global Virus-like Particle Sales by Region: 2018-2023
3.2.2 Global Virus-like Particle Sales by Region: 2024-2029
3.3 Global Virus-like Particle Global Virus-like Particle Revenue by Region: 2018-2029
3.3.1 Global Virus-like Particle Revenue by Region: 2018-2023
3.3.2 Global Virus-like Particle Revenue by Region: 2024-2029
3.4 North America Virus-like Particle Market Facts & Figures by Country
3.4.1 North America Virus-like Particle Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Virus-like Particle Sales by Country (2018-2029)
3.4.3 North America Virus-like Particle Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Virus-like Particle Market Facts & Figures by Country
3.5.1 Europe Virus-like Particle Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Virus-like Particle Sales by Country (2018-2029)
3.5.3 Europe Virus-like Particle Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Virus-like Particle Market Facts & Figures by Country
3.6.1 Asia Pacific Virus-like Particle Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Virus-like Particle Sales by Country (2018-2029)
3.6.3 Asia Pacific Virus-like Particle Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Virus-like Particle Market Facts & Figures by Country
3.7.1 Latin America Virus-like Particle Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Virus-like Particle Sales by Country (2018-2029)
3.7.3 Latin America Virus-like Particle Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Virus-like Particle Market Facts & Figures by Country
3.8.1 Middle East and Africa Virus-like Particle Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Virus-like Particle Sales by Country (2018-2029)
3.8.3 Middle East and Africa Virus-like Particle Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Virus-like Particle Sales by Type (2018-2029)
4.1.1 Global Virus-like Particle Sales by Type (2018-2023)
4.1.2 Global Virus-like Particle Sales by Type (2024-2029)
4.1.3 Global Virus-like Particle Sales Market Share by Type (2018-2029)
4.2 Global Virus-like Particle Revenue by Type (2018-2029)
4.2.1 Global Virus-like Particle Revenue by Type (2018-2023)
4.2.2 Global Virus-like Particle Revenue by Type (2024-2029)
4.2.3 Global Virus-like Particle Revenue Market Share by Type (2018-2029)
4.3 Global Virus-like Particle Price by Type (2018-2029)
5 Segment by Application
5.1 Global Virus-like Particle Sales by Application (2018-2029)
5.1.1 Global Virus-like Particle Sales by Application (2018-2023)
5.1.2 Global Virus-like Particle Sales by Application (2024-2029)
5.1.3 Global Virus-like Particle Sales Market Share by Application (2018-2029)
5.2 Global Virus-like Particle Revenue by Application (2018-2029)
5.2.1 Global Virus-like Particle Revenue by Application (2018-2023)
5.2.2 Global Virus-like Particle Revenue by Application (2024-2029)
5.2.3 Global Virus-like Particle Revenue Market Share by Application (2018-2029)
5.3 Global Virus-like Particle Price by Application (2018-2029)
6 Key Companies Profiled
6.1 The Native Antigen Company
6.1.1 The Native Antigen Company Corporation Information
6.1.2 The Native Antigen Company Description and Business Overview
6.1.3 The Native Antigen Company Virus-like Particle Sales, Revenue and Gross Margin (2018-2023)
6.1.4 The Native Antigen Company Virus-like Particle Product Portfolio
6.1.5 The Native Antigen Company Recent Developments/Updates
6.2 Creative BioStructure
6.2.1 Creative BioStructure Corporation Information
6.2.2 Creative BioStructure Description and Business Overview
6.2.3 Creative BioStructure Virus-like Particle Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Creative BioStructure Virus-like Particle Product Portfolio
6.2.5 Creative BioStructure Recent Developments/Updates
6.3 Creative Biolabs
6.3.1 Creative Biolabs Corporation Information
6.3.2 Creative Biolabs Description and Business Overview
6.3.3 Creative Biolabs Virus-like Particle Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Creative Biolabs Virus-like Particle Product Portfolio
6.3.5 Creative Biolabs Recent Developments/Updates
6.4 Leadgene Biomedical
6.4.1 Leadgene Biomedical Corporation Information
6.4.2 Leadgene Biomedical Description and Business Overview
6.4.3 Leadgene Biomedical Virus-like Particle Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Leadgene Biomedical Virus-like Particle Product Portfolio
6.4.5 Leadgene Biomedical Recent Developments/Updates
6.5 Abcam
6.5.1 Abcam Corporation Information
6.5.2 Abcam Description and Business Overview
6.5.3 Abcam Virus-like Particle Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Abcam Virus-like Particle Product Portfolio
6.5.5 Abcam Recent Developments/Updates
6.6 ACROBiosystems
6.6.1 ACROBiosystems Corporation Information
6.6.2 ACROBiosystems Description and Business Overview
6.6.3 ACROBiosystems Virus-like Particle Sales, Revenue and Gross Margin (2018-2023)
6.6.4 ACROBiosystems Virus-like Particle Product Portfolio
6.6.5 ACROBiosystems Recent Developments/Updates
6.7 Gentarget
6.6.1 Gentarget Corporation Information
6.6.2 Gentarget Description and Business Overview
6.6.3 Gentarget Virus-like Particle Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Gentarget Virus-like Particle Product Portfolio
6.7.5 Gentarget Recent Developments/Updates
6.8 VectorBuilder
6.8.1 VectorBuilder Corporation Information
6.8.2 VectorBuilder Description and Business Overview
6.8.3 VectorBuilder Virus-like Particle Sales, Revenue and Gross Margin (2018-2023)
6.8.4 VectorBuilder Virus-like Particle Product Portfolio
6.8.5 VectorBuilder Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Virus-like Particle Industry Chain Analysis
7.2 Virus-like Particle Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Virus-like Particle Production Mode & Process
7.4 Virus-like Particle Sales and Marketing
7.4.1 Virus-like Particle Sales Channels
7.4.2 Virus-like Particle Distributors
7.5 Virus-like Particle Customers
8 Virus-like Particle Market Dynamics
8.1 Virus-like Particle Industry Trends
8.2 Virus-like Particle Market Drivers
8.3 Virus-like Particle Market Challenges
8.4 Virus-like Particle Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Virus-like Particle Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Virus-like Particle Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Virus-like Particle Market Competitive Situation by Manufacturers in 2022
Table 4. Global Virus-like Particle Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Virus-like Particle Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Virus-like Particle Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Virus-like Particle Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Virus-like Particle Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Virus-like Particle, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Virus-like Particle, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Virus-like Particle, Product Type & Application
Table 12. Global Key Manufacturers of Virus-like Particle, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Virus-like Particle by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Virus-like Particle as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Virus-like Particle Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Virus-like Particle Sales by Region (2018-2023) & (K Units)
Table 18. Global Virus-like Particle Sales Market Share by Region (2018-2023)
Table 19. Global Virus-like Particle Sales by Region (2024-2029) & (K Units)
Table 20. Global Virus-like Particle Sales Market Share by Region (2024-2029)
Table 21. Global Virus-like Particle Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Virus-like Particle Revenue Market Share by Region (2018-2023)
Table 23. Global Virus-like Particle Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Virus-like Particle Revenue Market Share by Region (2024-2029)
Table 25. North America Virus-like Particle Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Virus-like Particle Sales by Country (2018-2023) & (K Units)
Table 27. North America Virus-like Particle Sales by Country (2024-2029) & (K Units)
Table 28. North America Virus-like Particle Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Virus-like Particle Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Virus-like Particle Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Virus-like Particle Sales by Country (2018-2023) & (K Units)
Table 32. Europe Virus-like Particle Sales by Country (2024-2029) & (K Units)
Table 33. Europe Virus-like Particle Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Virus-like Particle Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Virus-like Particle Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Virus-like Particle Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Virus-like Particle Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Virus-like Particle Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Virus-like Particle Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Virus-like Particle Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Virus-like Particle Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Virus-like Particle Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Virus-like Particle Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Virus-like Particle Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Virus-like Particle Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Virus-like Particle Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Virus-like Particle Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Virus-like Particle Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Virus-like Particle Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Virus-like Particle Sales (K Units) by Type (2018-2023)
Table 51. Global Virus-like Particle Sales (K Units) by Type (2024-2029)
Table 52. Global Virus-like Particle Sales Market Share by Type (2018-2023)
Table 53. Global Virus-like Particle Sales Market Share by Type (2024-2029)
Table 54. Global Virus-like Particle Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Virus-like Particle Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Virus-like Particle Revenue Market Share by Type (2018-2023)
Table 57. Global Virus-like Particle Revenue Market Share by Type (2024-2029)
Table 58. Global Virus-like Particle Price (US$/Unit) by Type (2018-2023)
Table 59. Global Virus-like Particle Price (US$/Unit) by Type (2024-2029)
Table 60. Global Virus-like Particle Sales (K Units) by Application (2018-2023)
Table 61. Global Virus-like Particle Sales (K Units) by Application (2024-2029)
Table 62. Global Virus-like Particle Sales Market Share by Application (2018-2023)
Table 63. Global Virus-like Particle Sales Market Share by Application (2024-2029)
Table 64. Global Virus-like Particle Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Virus-like Particle Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Virus-like Particle Revenue Market Share by Application (2018-2023)
Table 67. Global Virus-like Particle Revenue Market Share by Application (2024-2029)
Table 68. Global Virus-like Particle Price (US$/Unit) by Application (2018-2023)
Table 69. Global Virus-like Particle Price (US$/Unit) by Application (2024-2029)
Table 70. The Native Antigen Company Corporation Information
Table 71. The Native Antigen Company Description and Business Overview
Table 72. The Native Antigen Company Virus-like Particle Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. The Native Antigen Company Virus-like Particle Product
Table 74. The Native Antigen Company Recent Developments/Updates
Table 75. Creative BioStructure Corporation Information
Table 76. Creative BioStructure Description and Business Overview
Table 77. Creative BioStructure Virus-like Particle Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Creative BioStructure Virus-like Particle Product
Table 79. Creative BioStructure Recent Developments/Updates
Table 80. Creative Biolabs Corporation Information
Table 81. Creative Biolabs Description and Business Overview
Table 82. Creative Biolabs Virus-like Particle Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Creative Biolabs Virus-like Particle Product
Table 84. Creative Biolabs Recent Developments/Updates
Table 85. Leadgene Biomedical Corporation Information
Table 86. Leadgene Biomedical Description and Business Overview
Table 87. Leadgene Biomedical Virus-like Particle Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Leadgene Biomedical Virus-like Particle Product
Table 89. Leadgene Biomedical Recent Developments/Updates
Table 90. Abcam Corporation Information
Table 91. Abcam Description and Business Overview
Table 92. Abcam Virus-like Particle Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Abcam Virus-like Particle Product
Table 94. Abcam Recent Developments/Updates
Table 95. ACROBiosystems Corporation Information
Table 96. ACROBiosystems Description and Business Overview
Table 97. ACROBiosystems Virus-like Particle Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. ACROBiosystems Virus-like Particle Product
Table 99. ACROBiosystems Recent Developments/Updates
Table 100. Gentarget Corporation Information
Table 101. Gentarget Description and Business Overview
Table 102. Gentarget Virus-like Particle Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Gentarget Virus-like Particle Product
Table 104. Gentarget Recent Developments/Updates
Table 105. VectorBuilder Corporation Information
Table 106. VectorBuilder Description and Business Overview
Table 107. VectorBuilder Virus-like Particle Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. VectorBuilder Virus-like Particle Product
Table 109. VectorBuilder Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Virus-like Particle Distributors List
Table 113. Virus-like Particle Customers List
Table 114. Virus-like Particle Market Trends
Table 115. Virus-like Particle Market Drivers
Table 116. Virus-like Particle Market Challenges
Table 117. Virus-like Particle Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Virus-like Particle
Figure 2. Global Virus-like Particle Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Virus-like Particle Market Share by Type in 2022 & 2029
Figure 4. E. coli Product Picture
Figure 5. Yeast Product Picture
Figure 6. Insect Cells Product Picture
Figure 7. Others Product Picture
Figure 8. Global Virus-like Particle Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Virus-like Particle Market Share by Application in 2022 & 2029
Figure 10. Vaccine
Figure 11. Therapeutics
Figure 12. Bioimaging
Figure 13. Others
Figure 14. Global Virus-like Particle Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Virus-like Particle Market Size (2018-2029) & (US$ Million)
Figure 16. Global Virus-like Particle Sales (2018-2029) & (K Units)
Figure 17. Global Virus-like Particle Average Price (US$/Unit) & (2018-2029)
Figure 18. Virus-like Particle Report Years Considered
Figure 19. Virus-like Particle Sales Share by Manufacturers in 2022
Figure 20. Global Virus-like Particle Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest Virus-like Particle Players: Market Share by Revenue in 2022
Figure 22. Virus-like Particle Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 23. Global Virus-like Particle Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 24. North America Virus-like Particle Sales Market Share by Country (2018-2029)
Figure 25. North America Virus-like Particle Revenue Market Share by Country (2018-2029)
Figure 26. United States Virus-like Particle Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Canada Virus-like Particle Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Europe Virus-like Particle Sales Market Share by Country (2018-2029)
Figure 29. Europe Virus-like Particle Revenue Market Share by Country (2018-2029)
Figure 30. Germany Virus-like Particle Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Virus-like Particle Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Virus-like Particle Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Virus-like Particle Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Virus-like Particle Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Virus-like Particle Sales Market Share by Region (2018-2029)
Figure 36. Asia Pacific Virus-like Particle Revenue Market Share by Region (2018-2029)
Figure 37. China Virus-like Particle Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Japan Virus-like Particle Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. South Korea Virus-like Particle Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. India Virus-like Particle Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Australia Virus-like Particle Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. China Taiwan Virus-like Particle Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Indonesia Virus-like Particle Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Thailand Virus-like Particle Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Malaysia Virus-like Particle Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Latin America Virus-like Particle Sales Market Share by Country (2018-2029)
Figure 47. Latin America Virus-like Particle Revenue Market Share by Country (2018-2029)
Figure 48. Mexico Virus-like Particle Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Brazil Virus-like Particle Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Argentina Virus-like Particle Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa Virus-like Particle Sales Market Share by Country (2018-2029)
Figure 52. Middle East & Africa Virus-like Particle Revenue Market Share by Country (2018-2029)
Figure 53. Turkey Virus-like Particle Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Virus-like Particle Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. UAE Virus-like Particle Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Global Sales Market Share of Virus-like Particle by Type (2018-2029)
Figure 57. Global Revenue Market Share of Virus-like Particle by Type (2018-2029)
Figure 58. Global Virus-like Particle Price (US$/Unit) by Type (2018-2029)
Figure 59. Global Sales Market Share of Virus-like Particle by Application (2018-2029)
Figure 60. Global Revenue Market Share of Virus-like Particle by Application (2018-2029)
Figure 61. Global Virus-like Particle Price (US$/Unit) by Application (2018-2029)
Figure 62. Virus-like Particle Value Chain
Figure 63. Virus-like Particle Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • GMP細胞バンキングの世界市場2023年：哺乳類細胞、微生物細胞、昆虫細胞、その他
  • ウイルス精製キットの世界市場2023年：レトロウイルス、レンチウイルス、アデノウイルス、アデノ随伴ウイルス
  • ウイルス性喘息治療の世界市場2023年：経口、注射
  • サル痘ウイルスワクチンのグローバル市場展望 2023年-2029年：MVA-BN、LC16、オルソポックスバック
  • エクソソーム粒子サイズ分析装置の世界市場インサイト・予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8505 )"ウイルス様粒子の世界市場2023年：大腸菌、酵母、昆虫細胞、その他" (英文：Global Virus-like Particle Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。